4-Amino-5-aryl-6-arylethynylpyrimidines: Structure–activity relationships of non-nucleoside adenosine kinase inhibitors

~94%

~94%

~%

~%

~%

~%

~%

~%

~75%

~96%

~52%

~70%

~%

~%

~95%

~49%

~94%

~89%

~%

~66%

~%

~%

~%

~92%

~75%

~44%

~88%

~%

~%

~51%

~%

~%

~63%

~%

~%

~%

~77%

~%

~%

~%

~42%

~%

~64%